Literature DB >> 11607818

Common themes in the pathogenesis of acute myeloid leukemia.

M Alcalay1, A Orleth, C Sebastiani, N Meani, F Chiaradonna, C Casciari, M T Sciurpi, V Gelmetti, D Riganelli, S Minucci, M Fagioli, P G Pelicci.   

Abstract

The pathogenesis of acute myeloid leukemia is associated with the appearance of oncogenic fusion proteins generated as a consequence of specific chromosome translocations. Of the two components of each fusion protein, one is generally a transcription factor, whereas the other partner is more variable in function, but often involved in the control of cell survival and apoptosis. As a consequence, AML-associated fusion proteins function as aberrant transcriptional regulators that interfere with the process of myeloid differentiation, determine a stage-specific arrest of maturation and enhance cell survival in a cell-type specific manner. The abnormal regulation of transcriptional networks occurs through common mechanisms that include recruitment of aberrant co-repressor complexes, alterations in chromatin remodeling, and disruption of specific subnuclear compartments. The identification and analysis of common and specific target genes regulated by AML fusion proteins will be of fundamental importance for the full understanding of acute myeloid leukemogenesis and for the implementation of disease-specific drug design.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11607818     DOI: 10.1038/sj.onc.1204642

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity.

Authors:  Yizhou Liu; Wei Chen; Justin Gaudet; Matthew D Cheney; Liya Roudaia; Tomasz Cierpicki; Rachel C Klet; Kari Hartman; Thomas M Laue; Nancy A Speck; John H Bushweller
Journal:  Cancer Cell       Date:  2007-06       Impact factor: 31.743

2.  Lozenge directly activates argos and klumpfuss to regulate programmed cell death.

Authors:  Jill Wildonger; Alona Sosinsky; Barry Honig; Richard S Mann
Journal:  Genes Dev       Date:  2005-05-01       Impact factor: 11.361

Review 3.  Epidermal growth factor signaling in transformed cells.

Authors:  Stephan Lindsey; Sigrid A Langhans
Journal:  Int Rev Cell Mol Biol       Date:  2014-11-18       Impact factor: 6.813

4.  Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair.

Authors:  Myriam Alcalay; Natalia Meani; Vania Gelmetti; Anna Fantozzi; Marta Fagioli; Annette Orleth; Daniela Riganelli; Carla Sebastiani; Enrico Cappelli; Cristina Casciari; Maria Teresa Sciurpi; Angela Rosa Mariano; Simone Paolo Minardi; Lucilla Luzi; Heiko Muller; Pier Paolo Di Fiore; Guido Frosina; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 5.  Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

Authors:  Emmanuelle Passegué; Catriona H M Jamieson; Laurie E Ailles; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

6.  Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.

Authors:  Bo Cen; Ahalya Selvaraj; Rebecca C Burgess; Johann K Hitzler; Zhigui Ma; Stephan W Morris; Ron Prywes
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model.

Authors:  Haiyan Xu; Eric S Muise; Sarah Javaid; Lan Chen; Razvan Cristescu; My Sam Mansueto; Nicole Follmer; Jennifer Cho; Kimberley Kerr; Rachel Altura; Michelle Machacek; Benjamin Nicholson; George Addona; Ilona Kariv; Hongmin Chen
Journal:  J Cell Mol Med       Date:  2019-08-26       Impact factor: 5.310

8.  Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.

Authors:  Jingyi Zhang; Yuetong Wang; Chujie Yin; Ping Gong; Zhenwei Zhang; Linxiang Zhao; Samuel Waxman; Yongkui Jing
Journal:  Cell Death Dis       Date:  2022-04-20       Impact factor: 8.469

9.  Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia.

Authors:  Claudia Chiriches; Dilawar Khan; Maria Wieske; Nathalie Guillen; Michal Rokicki; Carol Guy; Marieangela Wilson; Kate J Heesom; Oliver Gerhard Ottmann; Martin Ruthardt
Journal:  Ann Hematol       Date:  2022-08-08       Impact factor: 4.030

10.  AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets.

Authors:  Alessandro Gardini; Matteo Cesaroni; Lucilla Luzi; Akiko J Okumura; Joseph R Biggs; Simone P Minardi; Elisa Venturini; Dong-Er Zhang; Pier Giuseppe Pelicci; Myriam Alcalay
Journal:  PLoS Genet       Date:  2008-11-28       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.